Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00919347 · ClinicalTrials.gov registry record
The Relative Prevalence and Severity of Autonomic Nervous System Dysfunction
A clinical trial, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 100
- Enrollment target
NCT00919347: Completed study, sponsored by University of Alabama at Birmingham.
NCT00919347 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00919347 has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
The purpose of this study is to measure the prevalence and severity of cardiac autonomic neuropathy (CAN), diabetic autonomic neuropathy (DAN) which in non-diabetics is termed advanced nervous system (ANS) dysfunction, and autonomic dysfunction as well as the overall sympathovagal balance (SB) in the CEFH population of diabetic patients versus non-diabetic patients undergoing elective vitreoretinal surgery.
Interventions
- OTHER ANSAR ANX 3.0 Software
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2009-06 |
| Est. Completion | 2010-05 |
What the finished NCT00919347 record still lists
NCT00919347 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which ANSAR ANX 3.0 Software is the first listed.
NCT00919347 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00919347 about?
NCT00919347 is a clinical study titled "The Relative Prevalence and Severity of Autonomic Nervous System Dysfunction". The purpose of this study is to measure the prevalence and severity of cardiac autonomic neuropathy (CAN), diabetic autonomic neuropathy (DAN) which in non-diabetics is termed advanced nervous system (ANS) dysfunction, and autonomic dysfunction as well as the overall sympathovagal balance (SB) in th...
What is the current status of trial NCT00919347?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2009-06. Estimated completion is 2010-05.
What interventions are being tested in trial NCT00919347?
The interventions under investigation include: ANSAR ANX 3.0 Software (OTHER).
Who is sponsoring clinical trial NCT00919347?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia